Open AccessPreliminary Characterization of NP339, a Novel Polyarginine Peptide with Broad Antifungal Activity
Author(s) -
Vanessa Duncan,
Daniel W. Smith,
Laura W. Simpson,
Emma Lovie,
Laura K. Katvars,
Leon Berge,
Jennifer Robertson,
Shane Smith,
Carol A. Munro,
Derry K. Mercer,
Deborah A. O′Neil
Publication year - 2021
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.02345-20
Subject(s) - biology , antifungal drug , cryptococcus neoformans , cryptococcus , drug , antifungal , microbiology and biotechnology , aspergillus , pharmacology
Fungi cause disease in nearly one billion individuals worldwide. Only three classes of antifungal agents are currently available in mainstream clinical use.